109 related articles for article (PubMed ID: 18043484)
1. Limited sampling strategies to estimate exposure to the green tea polyphenol, epigallocatechin gallate, in fasting and fed conditions.
Foster DR; Sowinski KM; Chow HH; Overholser BR
Ther Drug Monit; 2007 Dec; 29(6):835-42. PubMed ID: 18043484
[TBL] [Abstract][Full Text] [Related]
2. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
3. Development of an efficient sampling strategy to predict enoxaparin pharmacokinetics in stage 5 chronic kidney disease.
Overholser BR; Brophy DF; Sowinski KM
Ther Drug Monit; 2006 Dec; 28(6):807-12. PubMed ID: 17164698
[TBL] [Abstract][Full Text] [Related]
4. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.
Isbrucker RA; Edwards JA; Wolz E; Davidovich A; Bausch J
Food Chem Toxicol; 2006 May; 44(5):636-50. PubMed ID: 16387402
[TBL] [Abstract][Full Text] [Related]
5. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
7. Plasma appearance and correlation between coffee and green tea metabolites in human subjects.
Renouf M; Guy P; Marmet C; Longet K; Fraering AL; Moulin J; Barron D; Dionisi F; Cavin C; Steiling H; Williamson G
Br J Nutr; 2010 Dec; 104(11):1635-40. PubMed ID: 20691128
[TBL] [Abstract][Full Text] [Related]
8. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of the major active components of tea polyphenols in rat plasma by a simple and specific HPLC assay.
Fu T; Liang J; Han G; Lv L; Li N
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):363-7. PubMed ID: 18922746
[TBL] [Abstract][Full Text] [Related]
10. Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis).
Fung ST; Ho CK; Choi SW; Chung WY; Benzie IF
Br J Nutr; 2013 Jun; 109(12):2199-207. PubMed ID: 23110850
[TBL] [Abstract][Full Text] [Related]
11. Absorption and pharmacokinetics of green tea catechins in beagles.
Mata-Bilbao Mde L; Andrés-Lacueva C; Roura E; Jáuregui O; Escribano E; Torre C; Lamuela-Raventós RM
Br J Nutr; 2008 Sep; 100(3):496-502. PubMed ID: 18205995
[TBL] [Abstract][Full Text] [Related]
12. Solid-state NMR analysis of the orientation and dynamics of epigallocatechin gallate, a green tea polyphenol, incorporated into lipid bilayers.
Kajiya K; Kumazawa S; Naito A; Nakayama T
Magn Reson Chem; 2008 Feb; 46(2):174-7. PubMed ID: 18098154
[TBL] [Abstract][Full Text] [Related]
13. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review.
Thielecke F; Boschmann M
Phytochemistry; 2009 Jan; 70(1):11-24. PubMed ID: 19147161
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution.
Lin LC; Wang MN; Tseng TY; Sung JS; Tsai TH
J Agric Food Chem; 2007 Feb; 55(4):1517-24. PubMed ID: 17256961
[TBL] [Abstract][Full Text] [Related]
15. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.
Sang S; Lee MJ; Hou Z; Ho CT; Yang CS
J Agric Food Chem; 2005 Nov; 53(24):9478-84. PubMed ID: 16302765
[TBL] [Abstract][Full Text] [Related]
16. Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.
Kale A; Gawande S; Kotwal S; Netke S; Roomi W; Ivanov V; Niedzwiecki A; Rath M
Phytother Res; 2010 Jan; 24 Suppl 1():S48-55. PubMed ID: 19585479
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
19. Identification of green tea's (Camellia sinensis (L.)) quality level according to measurement of main catechins and caffeine contents by HPLC and support vector classification pattern recognition.
Chen Q; Guo Z; Zhao J
J Pharm Biomed Anal; 2008 Dec; 48(5):1321-5. PubMed ID: 18952392
[TBL] [Abstract][Full Text] [Related]
20. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate.
Navarro-Perán E; Cabezas-Herrera J; Campo LS; Rodríguez-López JN
Int J Biochem Cell Biol; 2007; 39(12):2215-25. PubMed ID: 17683969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
